Last reviewed · How we verify
Vasomotor symptoms associated with climacteric disturbance
Approved treatments
- Micronor · Johnson & Johnson
ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vasomotor symptoms associated with climacteric disturbance patent landscape — cliff calendar, originator estates, attackable patents
- Vasomotor symptoms associated with climacteric disturbance treatment landscape brief
- Vasomotor symptoms associated with climacteric disturbance treatment updates RSS
Frequently asked questions about Vasomotor symptoms associated with climacteric disturbance
What drugs treat Vasomotor symptoms associated with climacteric disturbance?
Tracked treatments include Micronor.
What is the treatment for Vasomotor symptoms associated with climacteric disturbance?
Standard treatment for Vasomotor symptoms associated with climacteric disturbance includes Micronor. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vasomotor symptoms associated with climacteric disturbance patent cliff · Vasomotor symptoms associated with climacteric disturbance CI report
- Treatment: Micronor · Johnson & Johnson
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing